233 related articles for article (PubMed ID: 18787762)
1. Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study.
Blakeley JO; Olson J; Grossman SA; He X; Weingart J; Supko JG;
J Neurooncol; 2009 Jan; 91(1):51-8. PubMed ID: 18787762
[TBL] [Abstract][Full Text] [Related]
2. Influence of C6 and CNS1 brain tumors on methotrexate pharmacokinetics in plasma and brain tissue.
Dukic SF; Kaltenbach ML; Heurtaux T; Hoizey G; Lallemand A; Vistelle R
J Neurooncol; 2004; 67(1-2):131-8. PubMed ID: 15072460
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats.
Dukic S; Heurtaux T; Kaltenbach ML; Hoizey G; Lallemand A; Gourdier B; Vistelle R
Pharm Res; 1999 Aug; 16(8):1219-25. PubMed ID: 10468023
[TBL] [Abstract][Full Text] [Related]
4. In vivo microdialysis to characterize drug transport in brain tumors: analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats.
Devineni D; Klein-Szanto A; Gallo JM
Cancer Chemother Pharmacol; 1996; 38(6):499-507. PubMed ID: 8823490
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.
Dhanikula RS; Argaw A; Bouchard JF; Hildgen P
Mol Pharm; 2008; 5(1):105-16. PubMed ID: 18171013
[TBL] [Abstract][Full Text] [Related]
6. The effect of ABCG2 and ABCC4 on the pharmacokinetics of methotrexate in the brain.
Sane R; Wu SP; Zhang R; Gallo JM
Drug Metab Dispos; 2014 Apr; 42(4):537-40. PubMed ID: 24464805
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of preclinical mouse models of high-grade glioma for nanomedicine research: the importance of reproducing blood-brain barrier heterogeneity.
Brighi C; Reid L; Genovesi LA; Kojic M; Millar A; Bruce Z; White AL; Day BW; Rose S; Whittaker AK; Puttick S
Theranostics; 2020; 10(14):6361-6371. PubMed ID: 32483457
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral retrograde microdialysis treatment of high-grade glioma with cisplatin.
Tabatabaei P; Asklund T; Bergström P; Björn E; Johansson M; Bergenheim AT
Acta Neurochir (Wien); 2020 Dec; 162(12):3043-3053. PubMed ID: 32666378
[TBL] [Abstract][Full Text] [Related]
10. Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma.
Watts RG; Merchant RE
Neurosurgery; 1992 Jul; 31(1):89-98; discussion 98-9. PubMed ID: 1641114
[TBL] [Abstract][Full Text] [Related]
11. A neuropharmacokinetic assessment of bafetinib, a second generation dual BCR-Abl/Lyn tyrosine kinase inhibitor, in patients with recurrent high-grade gliomas.
Portnow J; Badie B; Markel S; Liu A; D'Apuzzo M; Frankel P; Jandial R; Synold TW
Eur J Cancer; 2013 May; 49(7):1634-40. PubMed ID: 23380277
[TBL] [Abstract][Full Text] [Related]
12. Cerebral microdialysis in glioma studies, from theory to application.
Liu L; Zhang X; Lou Y; Rao Y; Zhang X
J Pharm Biomed Anal; 2014 Aug; 96():77-89. PubMed ID: 24747145
[TBL] [Abstract][Full Text] [Related]
13. Development of a dog microdialysis model for determining synovial fluid pharmacokinetics of anti-arthritis compounds exemplified by methotrexate.
Qian M; West W; Wu JT; Lu B; Christ DD
Pharm Res; 2003 Apr; 20(4):605-10. PubMed ID: 12739768
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study.
Hu Y; Rip J; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M
J Pharm Sci; 2017 Sep; 106(9):2606-2613. PubMed ID: 28322936
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis.
Apparaju SK; Gudelsky GA; Desai PB
Cancer Chemother Pharmacol; 2008 Feb; 61(2):223-9. PubMed ID: 17443325
[TBL] [Abstract][Full Text] [Related]
16. The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumor-bearing mice: a microdialysis study.
Sani SN; Henry K; Böhlke M; Kim J; Stricker-Krongrad A; Maher TJ
Cancer Chemother Pharmacol; 2010 May; 66(1):159-69. PubMed ID: 19816684
[TBL] [Abstract][Full Text] [Related]
17. Influence of schedule of administration on methotrexate penetration in brain tumours.
Dukic SF; Heurtaux T; Kaltenbach ML; Hoizey G; Lallemand A; Vistelle R
Eur J Cancer; 2000 Aug; 36(12):1578-84. PubMed ID: 10930807
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of letrozole in brain and brain tumor in rats with orthotopically implanted C6 glioma, assessed using intracerebral microdialysis.
Dave N; Gudelsky GA; Desai PB
Cancer Chemother Pharmacol; 2013 Aug; 72(2):349-57. PubMed ID: 23748921
[TBL] [Abstract][Full Text] [Related]
19. Continuous intratumoral microdialysis during high-dose methotrexate therapy in a patient with malignant fibrous histiocytoma of the femur: a case report.
Ekstrøm PO; Andersen A; Saeter G; Giercksky KE; Slørdal L
Cancer Chemother Pharmacol; 1997; 39(3):267-72. PubMed ID: 8996531
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of doxorubicin in glioblastoma multiforme following ultrasound-Induced blood-brain barrier disruption as determined by microdialysis.
Lin YL; Wu MT; Yang FY
J Pharm Biomed Anal; 2018 Feb; 149():482-487. PubMed ID: 29175555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
